*0012340290
*00520240930142558.0
*007ta
*008231020s2023    no a   e m    0   0 eng
*00901878nam a2200397 c 4500
*019  $bl
*020  $a9788230851166$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999922269860802201
*035  $a(NO-DIMO)8d6aed30-63dc-4161-833d-44d24dbd25de
*035  $a(NO-LaBS)48022222(bibid)
*035  $aoai:nb.no:pliktmonografi_000027559
*035  $aoai:nb.no:pliktmonografi_000027559
*040  $aNO-OsNB$bnob$erda
*0410 $aeng$beng$bnno
*060 4$aQW 168.5.C8
*097  $aUkat
*1001 $aErtesvåg, Nina Urke$d1989-$0(NO-TrBIB)1642068382997$4aut$_328368600
*24000$aAntibody responses after influenza and SARS-CoV-2 vaccination and infection$_328368700
*24510$aAntibody responses after influenza and SARS-CoV-2 vaccination and infection :$blessons across the ages$cNina Urke Ertesvåg
*264 1$a[Bergen], Norway$bUniversity of Bergen$c2023
*300  $a1 bind (varierende paginering)$billustrasjoner
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*502  $aAvhandling (ph.d.) - Universitetet i Bergen, 2023
*546  $aTekst på engelsk, sammendrag på engelsk og norsk
*650 2$aAntibodies$0(DNLM)D000906$_11266100
*650 2$aCOVID-19 Serological Testing$0(DNLM)D000087124$_290290400
*650 2$aInfluenza A virus$0(DNLM)D009980$_290290500
*650 2$aPost-Acute COVID-19 Syndrome$0(DNLM)D000094024$_219505800
*653 6$areport$_128546700
*7001 $aErtesvåg, Nina Urke$d1989-$0(NO-TrBIB)1642068382997$tAntibody responses after influenza and SARS-CoV-2 vaccination and infection$_328368600
*7102 $aUniversitetet i Bergen$0(NO-TrBIB)90063607$4dgg$4pbl$_10049500
*85640$uhttps://urn.nb.no/URN:NBN:no-nb_pliktmonografi_000027559$3Fulltekst$yNettbiblioteket$zDigital representasjon
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999920449695502202$b2023-11-01T01:55:58Z$z999920449695502202
^